Your browser doesn't support javascript.
loading
Prospective cohort study on the use of low molecular weight heparin calibrated anti-Xa assay for measurement of direct oral Xa inhibitors in ex vivo patient samples.
Lim, Ming Sheng; Hayes, Robert; Sharma, Archna; Kitiponchai, Tanun; Mohamed, Muhajir; Mcrae, Simon.
Afiliación
  • Lim MS; Department of Haematology, Launceston General Hospital, Launceston, Tas, Australia. Electronic address: mingsheng.lim@ths.tas.gov.au.
  • Hayes R; Department of Haematology, Launceston General Hospital, Launceston, Tas, Australia.
  • Sharma A; Department of Haematology, Royal Hobart Hospital, Hobart, Tas, Australia; University of Tasmania, Hobart, Tas, Australia.
  • Kitiponchai T; Department of Haematology, Launceston General Hospital, Launceston, Tas, Australia.
  • Mohamed M; Department of Haematology, Launceston General Hospital, Launceston, Tas, Australia; University of Tasmania, Hobart, Tas, Australia.
  • Mcrae S; Department of Haematology, Launceston General Hospital, Launceston, Tas, Australia.
Pathology ; 54(5): 599-605, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35414442
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Heparina de Bajo-Peso-Molecular / Rivaroxabán Tipo de estudio: Etiology_studies / Observational_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Pathology Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Heparina de Bajo-Peso-Molecular / Rivaroxabán Tipo de estudio: Etiology_studies / Observational_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Pathology Año: 2022 Tipo del documento: Article